FGL (Fibroblast Growth-Like) vs Larazotide

Overview

FGL (Fibroblast Growth-Like) and Larazotide are both healing & recovery peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares FGL (Fibroblast Growth-Like) and Larazotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. FGL (Fibroblast Growth-Like) is categorised under Healing & Recovery, while Larazotide falls under Healing & Recovery. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. FGL (Fibroblast Growth-Like): not FDA-approved; treated as a research compound. Larazotide: not FDA-approved; treated as a research compound.

Dosing. FGL (Fibroblast Growth-Like) is typically dosed at 1 mg (daily). Larazotide is typically dosed at 1-8 mg (three times daily).

Can you stack them?

Some protocols combine peptides, but stacking FGL (Fibroblast Growth-Like) and Larazotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between FGL (Fibroblast Growth-Like) and Larazotide?

FGL (Fibroblast Growth-Like) and Larazotide are both healing & recovery peptides, but they differ in mechanism, dosing, and regulatory status. FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound, whereas Larazotide is not FDA-approved; generally classified as a research compound.

What is FGL (Fibroblast Growth-Like) used for?

Neural repair peptide.

What is Larazotide used for?

Gut permeability regulator.

Can you take FGL (Fibroblast Growth-Like) and Larazotide together?

Some users combine peptides within a single protocol, but stacking FGL (Fibroblast Growth-Like) and Larazotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is FGL (Fibroblast Growth-Like) or Larazotide FDA-approved?

FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound. Larazotide is not FDA-approved; generally classified as a research compound.